{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:32:50Z","timestamp":1779917570569,"version":"3.53.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3425,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/s1535-6108(04)00051-0","type":"journal-article","created":{"date-parts":[[2004,4,9]],"date-time":"2004-04-09T09:21:41Z","timestamp":1081502501000},"page":"231-239","source":"Crossref","is-referenced-by-count":444,"title":["In vivo antitumor activity of NVP-AEW541\u2014A novel, potent, and selective inhibitor of the IGF-IR kinase"],"prefix":"10.1016","volume":"5","author":[{"given":"Carlos","family":"Garc\u0131\u0301a-Echeverr\u0131\u0301a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Mestan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Brueggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Capraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cozens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean B","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriano","family":"Fabbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Furet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Graus","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Liebetanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Martiny-Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ruetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S1535-6108(04)00051-0_BIB1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-5793(96)01370-1","article-title":"Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase","volume":"399","author":"Alessi","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0092-8674(88)90060-8","article-title":"Cdc 2 is a component of the M-phase specific histone H1 kinase","volume":"55","author":"Arion","year":"1988","journal-title":"Cell"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB3","first-page":"6237","article-title":"Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor","volume":"49","author":"Artega","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1432-1033.1992.tb16557.x","article-title":"Interaction between the cell cycle control protein p34cdc2 and p9CKShs","volume":"203","author":"Azzi","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB5","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/sj.onc.1203854","article-title":"The contradictions of the insulin-like growth factor 1 receptor","volume":"19","author":"Baserga","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1172\/JCI118820","article-title":"Bcr\/Abl expression stimulates integrin function in hematopoietic cell lines","volume":"98","author":"Bazzoni","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB7","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1074\/jbc.272.26.16170","article-title":"Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells","volume":"272","author":"Bhat","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB8","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1073\/pnas.93.14.7263","article-title":"Antisense RNA to the type I insulin-like growth factor receptor suppresses tumour growth and prevents invasion by rat prostate cancer cells in vivo","volume":"93","author":"Burfeind","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB9","unstructured":"Capraro, H.G., Furet, P., Garcia-Echeverria, C., and Manley, P.W. (2002). 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives. PCT International Patent Application Publication WO 02\/92599."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.cgt.7700126","article-title":"Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumourogenesis, alters the metastatic potential and prolongs survival in vivo","volume":"7","author":"Chernicky","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB11","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/MCB.14.7.4588","article-title":"A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor","volume":"14","author":"Coppola","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB12","first-page":"4013","article-title":"A soluble Insulin-like growth factor I receptor that induces apoptosis of tumour cells in vivo and inhibits tumourogenesis","volume":"56","author":"D'Ambrosio","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jcp.1041640126","article-title":"R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor","volume":"164","author":"De Angelis","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/08977199209021544","article-title":"Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells","volume":"6","author":"De Leon","year":"1992","journal-title":"Growth Factors"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB15","first-page":"3353","article-title":"A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion and metastasis of breast cancer","volume":"58","author":"Dunn","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0092-8674(74)90050-6","article-title":"Cellular tumourigenicity in nude mice","volume":"3","author":"Freedman","year":"1974","journal-title":"Cell"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"F\u00fcrstenberger","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0006-2952(96)00885-4","article-title":"Activation of PKC subtypes \u03b1,\u03b3,\u03b4,\u03f5,\u03b6 and \u03b7 by tumour promoting and non-tumour promoting agents","volume":"53","author":"Geiges","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J","article-title":"Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis","volume":"183","author":"Grimberg","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<223::AID-IJC9>3.0.CO;2-Z","article-title":"Expression of a kinase deficient IGF-IR suppresses tumourogenicity of rhabdomyosarcoma cells constitutively expressing a wild-type IGF-IR","volume":"76","author":"Kalebic","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1128\/MCB.10.2.464","article-title":"Overexpression of the human insulin-like growth factor I receptor promotes ligand dependent neoplastic transformation","volume":"10","author":"Kaleko","year":"1990","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB22","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0021-9258(18)53824-2","article-title":"Role of tyrosine kinase activity in signal transduction by the insulin-like growth factors (IGF-I) receptor","volume":"268","author":"Kato","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumourogenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB24","first-page":"3909","article-title":"Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumour growth","volume":"60","author":"Li","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB25","first-page":"1006","article-title":"Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to insulin-like growth factor receptor","volume":"55","author":"Long","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1535-6108(02)00055-7","article-title":"Elevated levels of the IGF-I receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumourogenesis","volume":"1","author":"Lopez","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1432-1033.1992.tb17047.x","article-title":"Large scale purification and characterization of a recombinant epidermal growth factor receptor protein tyrosine kinase","volume":"207","author":"McGlynn","year":"1992","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1535-6108(04)00050-9","article-title":"Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors","volume":"5","author":"Mitsiades","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB29","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/j.1460-2075.1989.tb08353.x","article-title":"Cyclin is a component of the sea urchin egg M-Phase specific histone H1 kinase","volume":"8","author":"Meijer","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB30","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/j.1460-2075.1989.tb08353.x","article-title":"Cyclin B targets p34cdc2 for tyrosine phosphorylation","volume":"8","author":"Meijer","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB31","first-page":"760","article-title":"Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines","volume":"60","author":"Nakamura","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1073\/pnas.91.6.2181","article-title":"Dominant negative inhibition of tumourogenesis in vivo by human insulin-like growth factor I receptor mutant","volume":"91","author":"Prager","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/MCB.14.3.1575","article-title":"Involvement of Shc in Insulin- and Epidermal Growth Factor-induced activation of p21ras","volume":"14","author":"Pronk","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB34","first-page":"4848","article-title":"Growth inhibition of human melanoma cells in nude mice by antisense strategies to type 1 insulin-like growth factor receptor","volume":"54","author":"Resnicoff","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB35","first-page":"3739","article-title":"Correlation between apoptosis, tumourogenesis and the levels of insulin-like growth factor I receptor","volume":"55","author":"Resnicoff","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB36","first-page":"2647","article-title":"Inhibition of tumour growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect","volume":"4","author":"Reiss","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB37","first-page":"1581","article-title":"A new screening test for antimitotic compounds using universal M phase-specific protein kinase, p34cdc2\/cyclin Bcdc13, affinity-immobilized on p13suc1-coated microtitration plates","volume":"11","author":"Rialet","year":"1991","journal-title":"Anticancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB38","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1089\/104303401753204544","article-title":"Inhibition of carcinoma cell growth and metastasis by a vesicular stomatitis virus G-pseudotyped retrovector expressing type I insulin-like growth factor receptor antisense","volume":"12","author":"Samani","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB39","first-page":"4127","article-title":"Blockage of insulin-like growth factor I receptor inhibits the growth of Ewing's sarcoma in athymic mice","volume":"58","author":"Scotlandi","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ijc.10537","article-title":"Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumourogenesis and enhances chemosensitivity in Ewing's sarcoma cells","volume":"101","author":"Scotlandi","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.cgt.7700442","article-title":"Effectiveness of insulin-like growth factor I receptor antisense strategy againstEwing's sarcoma cells","volume":"9","author":"Scotlandi","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB42","doi-asserted-by":"crossref","first-page":"11217","DOI":"10.1073\/pnas.90.23.11217","article-title":"Simian virus 40 large tumour antigen is unable to transform mouse embryonic fibroblasts lacking type I Insulin-like growth factor receptor","volume":"90","author":"Sell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB43","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1128\/MCB.14.6.3604","article-title":"Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts","volume":"14","author":"Sell","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI117441","article-title":"Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma","volume":"94","author":"Shapiro","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0076-6879(91)00179-Z","article-title":"Expression of protein kinase C isotypes in baculovirus vectors","volume":"200","author":"Stabel","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1073\/pnas.76.3.1279","article-title":"Dual control of cell growth by somatomedins and platelet-derived growth factor","volume":"76","author":"Stiles","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB48","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/MCB.17.7.3744","article-title":"Insulin-like growth factor I receptor signaling in transformation by Src oncogenes","volume":"17","author":"Valentinis","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.cellbio.10.1.251","article-title":"Receptor protein-tyrosine kinases and their signal transduction pathways","volume":"10","author":"Van der Geer","year":"1994","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568009023333863","article-title":"Insulin-like growth factor receptor-1 as an anti-cancer target","volume":"2","author":"Wang","year":"2002","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/oli.1.2000.10.195","article-title":"Antisense inhibition of IGF-I receptor expression in HaCaT keratinocytes","volume":"10","author":"White","year":"2000","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"10.1016\/S1535-6108(04)00051-0_BIB52","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1073\/pnas.89.7.2922","article-title":"Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase","volume":"89","author":"Williams","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(04)00051-0_BIB53","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:17:21Z","timestamp":1623763041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610804000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S1535610804000510"],"URL":"https:\/\/doi.org\/10.1016\/s1535-6108(04)00051-0","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}